简化决策规则:临床评估联合D-二聚体排除深静脉血栓
基于四项前瞻性诊断研究的3368例疑似DVT患者个体数据,开发了仅含3项(小腿肿胀、DVT为最可能诊断、D-二聚体)的简化决策规则。低临床验前概率且D-二聚体<500 ng/mL、低概率且D-二聚体500-1000 ng/mL、高概率且D-二聚体<500 ng/mL三组DVT患病率均低于2%,可安全排除DVT,但需前瞻性验证。
要点
- 新规则仅含小腿肿胀、DVT为最可能诊断和D-二聚体3项,简单易用。
- 低概率且D-二聚体<500 ng/mL者DVT患病率0.1%(95%CI 0.0-0.8),可安全排除。
- 低概率且D-二聚体500-1000 ng/mL或高概率且D-二聚体<500 ng/mL者患病率均0.3%,可安全排除。
核心结论
- D-二聚体联合Wells条目形成的3项简化规则可安全排除DVT,但需前瞻性验证。
研究设计与样本
- 使用疑似DVT患者的前瞻性诊断研究个体数据进行新决策规则开发,主要结局为初始检查或随访期间DVT存在。
- 共纳入4项研究、3368例患者,总体DVT患病率为17%。
主要发现
- 新规则纳入D-二聚体、小腿肿胀和DVT为最可能诊断两个临床变量,定义低概率(两项均无)和高概率(至少一项存在)两组。
- 低概率且D-二聚体<500 ng/mL者DVT患病率0.1%(95%CI 0.0-0.8)。
- 低概率且D-二聚体500-1000 ng/mL者DVT患病率0.3%(95%CI 0.0-1.7)。
- 高概率且D-二聚体<500 ng/mL者DVT患病率0.3%(95%CI 0.0-1.0)。
关键数值与推荐
- 安全排除标准为DVT患病率95%CI上限<2%。
- 低概率且D-二聚体<500 ng/mL、低概率且D-二聚体500-1000 ng/mL、高概率且D-二聚体<500 ng/mL三种情况符合安全排除标准。
临床怎么用
- 对疑似DVT患者可先评估小腿肿胀和DVT为最可能诊断两项临床特征,分为低或高临床验前概率。
- 结合D-二聚体结果,符合上述三种组合者可考虑安全排除DVT。
局限性
- 结果为回顾性分析个体数据开发,需前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Current clinical decision rules to exclude deep vein thrombosis (DVT) are underused partly because of their complexity. A simplified rule that can be easily applied would be more appealing to use in clinical practice. METHODS: We used individual patient data from prospective diagnostic studies of patients suspected of DVT to develop a new clinical decision rule. The primary outcome was presence of DVT either at initial testing or during follow-up. DVT was considered safely excluded if the upper 95% confidence interval (CI) of DVT prevalence was <2%. RESULTS: Four studies and 3368 patients were eligible for this analysis. Overall prevalence of DVT was 17%. In addition to D-dimer, two variables, calf swelling and DVT as the most likely diagnosis, are included in the new rule. Based on these two variables, two clinical pretest probability (CPTP) groups were defined; low (none of the two items present) and high (at least one of the items present). DVT can be safely excluded in patients with low CPTP with a D-dimer <500 ng/mL (prevalence = 0.1%; 95% CI, 0.0-0.8), low CPTP with a D-dimer between 500 ng/ml and 1000 ng/ml (prevalence = 0.3%; 95% CI, 0.0-1.7), and D-dimer <500 ng/ml in patients with high CPTP (prevalence = 0.3%; 95% CI, 0.0-1.0). CONCLUSIONS: The combination of D-dimer and Wells items resulted in a simple clinical decision rule with 3 items. The results suggest that the rule can safely exclude DVT. Prospective validation is required.
引用
- Xu K, de Wit K, Geersing GJ, et al. A simplified decision rule to rule out deep vein thrombosis using clinical assessment and D-dimer. J Thromb Haemost. 2021. PMID: 33834620. doi:10.1111/jth.15337
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。